BRIEF published on 04/08/2025 at 07:05, 7 days 21 hours ago Nyxoah informe sur le processus d'approbation du système Genio par la FDA Technologie Médicale Approbation De La FDA Nyxoah Apnée Obstructive Du Sommeil Système Genio
BRIEF published on 04/08/2025 at 07:05, 7 days 21 hours ago Nyxoah Updates on FDA Approval Process for Genio System FDA Approval Medical Technology Nyxoah Obstructive Sleep Apnea Genio System
PRESS RELEASE published on 04/08/2025 at 07:00, 7 days 21 hours ago Nyxoah Provides Update on FDA Approvable Letter for Genio System Nyxoah provides update on FDA Approvable Letter for Genio System, expecting full PMA approval in Q2 2025 after addressing final requirements FDA Nyxoah Genio System Approvable Letter PMA Approval
BRIEF published on 03/26/2025 at 09:50, 20 days 18 hours ago Lettre d'approbation de la FDA délivrée à Nyxoah pour le système Genio® Approbation De La FDA Apnée Obstructive Du Sommeil Nyxoah SA Système Genio Thérapie De Neuromodulation
BRIEF published on 03/26/2025 at 09:50, 20 days 18 hours ago FDA Approvable Letter Issued to Nyxoah for Genio® System FDA Approval Obstructive Sleep Apnea Nyxoah SA Genio System Neuromodulation Therapy
PRESS RELEASE published on 03/26/2025 at 09:45, 20 days 18 hours ago FDA Issues Nyxoah an Approvable Letter for its Genio® System FDA issues an Approvable Letter to Nyxoah for its Genio® System, a breakthrough treatment for Obstructive Sleep Apnea (OSA) through neuromodulation. Nyxoah to work closely with FDA for U.S. market approval FDA Nyxoah Obstructive Sleep Apnea Genio System Approvable Letter
BRIEF published on 03/13/2025 at 07:05, 1 month 2 days ago Nyxoah annonce de solides résultats financiers pour 2024 Approbation De La FDA Résultats Financiers 2024 Apnée Obstructive Du Sommeil Nyxoah SA Système Genio
BRIEF published on 03/13/2025 at 07:05, 1 month 2 days ago Nyxoah Reports Strong Financial Results for 2024 FDA Approval 2024 Financial Results Obstructive Sleep Apnea Nyxoah SA Genio System
PRESS RELEASE published on 03/13/2025 at 07:00, 1 month 2 days ago Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results Nyxoah reports financial and operating results for Q4 and FY 2024, FDA PMA application nears conclusion, positioned for US launch in Q1 2025. Revenue up, cash position strong FDA Financial Results Nyxoah PMA Application US Launch
BRIEF published on 02/19/2025 at 07:10, 1 month 24 days ago Nyxoah Launches Genio® Therapy in Middle East Medical Technology Nyxoah Obstructive Sleep Apnea Middle East Market Genio® Launch
Published on 04/16/2025 at 02:25, 1 hour 46 minutes ago New High-Grade Assays Extend Tolmer Silver & Gold Zones
Published on 04/15/2025 at 23:40, 4 hours 31 minutes ago Electric Metals Announces Business Consulting Services Agreement With Terrella Capital
Published on 04/15/2025 at 23:30, 4 hours 41 minutes ago GameSquare Holdings Reports 2024 Full Year Results
Published on 04/15/2025 at 23:30, 4 hours 41 minutes ago AIML Announces Closing of Oversubscribed Private Placement
Published on 04/15/2025 at 23:00, 5 hours 11 minutes ago Cerrado Gold Announces Q1 2025 Production Results At Its Minera Don Nicolas Mine In Argentina
Published on 04/15/2025 at 23:54, 4 hours 17 minutes ago EQS-Adhoc: DATAGROUP enters into an Investment Agreement with and supports a public purchase offer of KKR at a price of EUR 54.00 per share in cash
Published on 04/15/2025 at 21:51, 6 hours 20 minutes ago EQS-Adhoc: Adtran Networks SE updates preliminary results for the financial year 2024
Published on 04/15/2025 at 18:53, 9 hours 18 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/15/2025 at 18:30, 9 hours 41 minutes ago GURIT REPORTS NET SALES OF CHF 85.2 MILLION IN THE FIRST QUARTER OF 2025; ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS
Published on 04/15/2025 at 18:00, 10 hours 11 minutes ago ALTHEORA: RESILIENCE DES RESULTATS ANNUELS 2024
Published on 04/15/2025 at 19:00, 9 hours 11 minutes ago Covivio Hotels - Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte des actionnaires du 15 avril 2025
Published on 04/15/2025 at 18:00, 10 hours 11 minutes ago NFL Biosciences annonce la mise à disposition de son rapport financier annuel 2024
Published on 04/15/2025 at 18:00, 10 hours 11 minutes ago Covivio Hotels - Revenus à fin mars 2025 : la croissance se poursuit
Published on 04/15/2025 at 18:00, 10 hours 11 minutes ago Covivio Hotels - Revenues at end-March 2025: continued growth
Published on 04/15/2025 at 17:45, 10 hours 26 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 mars 2025
